Design and synthesis of pyridine-pyrazolopyridine-based inhibitors of protein kinase B/Akt

被引：61

作者：

Zhu, Gui-Dong ^{[1
]}

Gong, Jianchun ^{[1
]}

Gandhi, Viraj B. ^{[1
]}

Woods, Keith ^{[1
]}

Luo, Yan ^{[1
]}

Liu, Xuesong ^{[1
]}

Guan, Ran ^{[1
]}

Klinghofer, Vered ^{[1
]}

Johnson, Eric F. ^{[1
]}

Stoll, Vincent S. ^{[1
]}

Marno, Mulugeta ^{[1
]}

Li, Qun ^{[1
]}

Rosenberg, Saul H. ^{[1
]}

Giranda, Vincent L. ^{[1
]}

机构：

[1] Abbott Labs, GPRD, Abbott Pk, IL 60064 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2007年 / 15卷 / 06期

关键词：

protein kinase B; Akt inhibitor; serine/threonine kinase; pyrazolopyridine;

D O I：

10.1016/j.bmc.2007.01.010

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Thr-211 is one of three different amino acid residues in the kinase domain of protein kinase B/Akt as compared to protein kinase A (PKA), a closely related analog in the same AGC family. In an attempt to improve the potency and selectivity of our indazole-pyridine series of Akt inhibitors over PKA, efforts have focused on the incorporation of a chemical functionality to interact with the hydroxy group of Thr-211. Several substituents including an oxygen anion, amino, and nitro groups have been introduced at the C-6 position of the indazole scaffold, leading to a significant drop in Akt potency. Incorporation of a nitrogen atom into the phenyl ring at the same position (i.e., 9f) maintained the Akt activity and, in some cases, improved the selectivity over PKA. The structure-activity relationships of the new pyridine-pyrazolopyridine series of Akt inhibitors and their structural features when bound to PKA are also discussed. (c) 2007 Elsevier Ltd. All rights reserved.

引用

页码：2441 / 2452

页数：12

共 50 条

[21] Synthesis of Protein Kinase Inhibitors
Scarpitta, Francesca
Canavesi, Augusto
Jegorov, Alexandr
CHEMICKE LISTY, 2011, 105 (04): : 278 - 281
[22] Pyrazolopyridine inhibitors of B-RafV600E. Part 4: Rational design and kinase selectivity profile of cell potent type II inhibitors
Wenglowsky, Steve
Moreno, David
Laird, Ellen R.
Gloor, Susan L.
Ren, Li
Risom, Tyler
Rudolph, Joachim
Sturgis, Hillary L.
Voegtli, Walter C.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (19) : 6237 - 6241
[23] Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B
Collins, I
Caldwell, J
Fonseca, T
Donald, A
Bavetsias, V
Hunter, LJK
Garrett, MD
Rowlands, MG
Aherne, GW
Davies, TG
Berdini, V
Woodhead, SJ
Davis, D
Seavers, LCA
Wyatt, PG
Workman, P
McDonald, E
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (04) : 1255 - 1273
[24] Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase a and mutants
Breitenlechner, CB
Friebe, WG
Brunet, E
Guido, W
Graul, M
Thomas, U
Künkele, KP
Schäfer, W
Gassel, M
Bosseineyer, D
Huber, R
Engh, RA
Masjost, B
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (01) : 163 - 170
[25] Design and campaign synthesis of pyridine-based histone deacetylase inhibitors
Andrews, David M.
Gibson, Keith M.
Graham, Mark A.
Matusiak, Zbigniew S.
Roberts, Craig A.
Stokes, Elaine S. E.
Brady, Madeleine C.
Chresta, Christine M.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (08) : 2525 - 2529
[26] Design, synthesis and biological evaluation of thrombin inhibitors based on a pyridine scaffold
Blomberg, David
Fex, Tomas
Xue, Yafeng
Brickmann, Kay
Kihlberg, Jan
ORGANIC & BIOMOLECULAR CHEMISTRY, 2007, 5 (16) : 2599 - 2605
[27] Discovery of New Pyrazolopyridine, Furopyridine, and Pyridine Derivatives as CDK2 Inhibitors: Design, Synthesis, Docking Studies, and Anti-Proliferative Activity
Abdel-Rahman, Adel A-H
Shaban, Amira K. F.
Nassar, Ibrahim F.
EL-Kady, Dina S.
Ismail, Nasser S. M.
Mahmoud, Samy F.
Awad, Hanem M.
El-Sayed, Wael A.
MOLECULES, 2021, 26 (13):
[28] Fragment-Based Discovery of Inhibitors of Protein Kinase B
Davies, Thomas G.
Woodhead, Steven J.
Collins, Ian
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2009, 9 (18) : 1705 - 1717
[29] THE DESIGN AND SYNTHESIS OF ETHER LIPID INHIBITORS OF PROTEIN-KINASE-C
MARASCO, CJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 73 - MEDI
[30] Physiological functions of protein kinase B/Akt
Yang, ZZ
Tschopp, O
Baudry, A
Dümmler, B
Hynx, D
Hemmings, BA
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 : 350 - 354

← 1 2 3 4 5 →